Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-24-000030

Chief Financial Officer acquired 21,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Goeltz II Robert C. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-23 Grant or award : show line 1 in the form +21,300 73,131 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-23 Grant or award : show line 2 in the form Stock Option (right to buy) +86,600 86,600 D
Loading xslF345X05/wk-form4_1706229604.xml…